High-attenuation areas on chest computed tomography and clinical respiratory outcomes in community-dwelling adults

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 11, 2017, Pages 1434-1442

  Podolanczuk, Anna J ^a   Oelsner, Elizabeth C ^a   Barr, R Graham ^a   Bernstein, Elana J ^a   Hoffman, Eric A ^b   Easthausen, Imaani J ^a   Stukovsky, Karen Hinckley ^c   RoyChoudhury, Arindam ^a   Michos, Erin D ^d   Raghu, Ganesh ^c   Kawut, Steven M ^e,f   Lederer, David J ^a  

^a Department of Medicine   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epidemiology; Hospitalizations; Mortality; Pulmonary fibrosis; Subclinical interstitial lung disease

Indexed keywords

AGED; COHORT ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85038097780     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201703-0555OC     Document Type: Article

References (34)

1. Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med 2014;2:566–572.
2. Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc 2014;11:1176–1185.
3. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, Taylor DO, Kucheryavaya AY, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report—2008. J Heart Lung Transplant 2008;27:957–969.
4. Rosas IO, Dellaripa PF, Lederer DJ, Khanna D, Young LR, Martinez FJ. Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc 2014;11(Suppl 3): S169–S177.
5. Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, Nishino M, Araki T, Zazueta OE, Kurugol S, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 2013; 368:2192–2200.
6. Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013;268:563–571.
7. Doyle TJ, Washko GR, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Divo MJ, Celli BR, Sciurba FC, Silverman EK, et al.; COPDGene Investigators. Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med 2012;185: 756–762.
8. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estépar RS, Lynch DA, Brehm JM, et al.; COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364:897–906.
9. Washko GR, Lynch DA, Matsuoka S, Ross JC, Umeoka S, Diaz A, Sciurba FC, Hunninghake GM, San José Estépar R, Silverman EK, et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 2010;17:48–53.
10. Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, Okajima Y, Dupuis J, Latourelle JC, Cho MH, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators; COPDGene Investigators. Association between interstitial lung abnormalities and all-cause mortality. JAMA 2016;315:672–681.
11. Araki T, Putman RK, Hatabu H, Gao W, Dupuis J, Latourelle JC, Nishino M, Zazueta OE, Kurugol S, Ross JC, et al. Development and progression of interstitial lung abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med 2016;194:1514–1522.
12. Podolanczuk AJ, Oelsner EC, Barr RG, Hoffman EA, Armstrong HF, Austin JH, Basner RC, Bartels MN, Christie JD, Enright PL, et al. High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. Eur Respir J 2016;48: 1442–1452.
13. Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, van Beek EJ, Austin JH, Jiang R, Lovasi GS, Barr RG. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study. Am J Respir Crit Care Med 2009;180:407–414.
14. Podolanczuk AJ, Oelsner E, Barr RG, Hoffman EA, Easthausen IJ, Enright PL, Hinckley Stukovsky KD, RoyChoudhury A, Michos ED, Raghu G, et al. High attenuation areas on chest CT and clinical respiratory outcomes in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis (MESA) [abstract]. Am J Respir Crit Care Med 2017;195:A7418.
15. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156: 871–881.
16. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR Jr, Sidney S, Bild DE, Williams OD, Detrano RC. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005;234:35–43.
17. Hoffman EA, Jiang R, Baumhauer H, Brooks MA, Carr JJ, Detrano R, Reinhardt J, Rodriguez J, Stukovsky K, Wong ND, et al. Reproducibility and validity of lung density measures from cardiac CT scans—the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Acad Radiol 2009;16:689–699.
18. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152: 653–657.
19. Oelsner EC, Carr JJ, Enright PL, Hoffman EA, Folsom AR, Kawut SM, Kronmal RA, Lederer DJ, Lima JA, Lovasi GS, et al. Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study. Thorax 2016;71:624–632.
20. Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE Jr, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, et al.; IPFnet investigators. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med 2015;3:388–396.
21. Lin DY, Wei LJ, Yang I, Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J R Stat Soc Series B Stat Methodol 2000;62:711–730.
22. Fong C, Ratkovic M, Hazlett C, Yang X, Imai K. CBPS: covariate balancing propensity score. R package version 0.12. 2016.
23. Feng P, Zhou XH, Zou QM, Fan MY, Li XS. Generalized propensity score for estimating the average treatment effect of multiple treatments. Stat Med 2012;31:681–697.
24. Imai K, van Dyk DA. Causal inference with general treatment regimes: generalizing the propensity score. J Am Stat Assoc 2004;99: 854–866.
25. Imai K, Ratkovic M. Covariate balancing propensity score. J R Stat Soc Series B Stat Methodol 2014;76:243–263.
26. Imbens GW. The role of the propensity score in estimating dose–response functions. Biometrika 2000;87:706–710.
27. Ramsey J, Ripley B. pspline: penalized smoothing splines. R package version 1.0-17.2015.
28. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16: 219–242.
29. Bernstein EJ, Barr RG, Austin JHM, Kawut SM, Raghu G, Sell JL, Hoffman EA, Newell JD Jr, Watts JR Jr, Nath PH, et al. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Thorax 2016;71: 1082–1090.
30. Kliment CR, Araki T, Doyle TJ, Gao W, Dupuis J, Latourelle JC, Zazueta OE, Fernandez IE, Nishino M, Okajima Y, et al. A comparison of visual and quantitative methods to identify interstitial lung abnormalities. BMC Pulm Med 2015;15:134.
31. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362:217–227.
32. Castaldi PJ, San José Estépar R, Mendoza CS, Hersh CP, Laird N, Crapo JD, Lynch DA, Silverman EK, Washko GR. Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med 2013;188:1083–1090.
33. Kong X, Cho MH, Anderson W, Coxson HO, Muller N, Washko G, Hoffman EA, Bakke P, Gulsvik A, Lomas DA, et al.; ECLIPSE Study NETT Investigators. Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med 2011;183:43–49.
34. Hersh CP, Washko GR, Jacobson FL, Gill R, Estepar RS, Reilly JJ, Silverman EK. Interobserver variability in the determination of upper lobe-predominant emphysema. Chest 2007;131:424–431.